La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Economic comparisons of the pharmacotherapy of depression: an overview

Identifieur interne : 003985 ( Main/Exploration ); précédent : 003984; suivant : 003986

Economic comparisons of the pharmacotherapy of depression: an overview

Auteurs : R. Crott [Canada] ; P. Gilis [Belgique]

Source :

RBID : ISTEX:012ACD1C71D7DE54000254AC9B500D3543F595B8

English descriptors

Abstract

As many countries find that their health care expenditure is taking up an increasing proportion of their financial resources, economic aspects of care processes have become more important in the choice of optimal strategies. This review of the economic studies of the comparative treatment of depression shows that nearly every aspect of treatment has important economic consequences. Cost‐of‐illness studies have documented the high burden on society of this disorder, and the associated loss of productivity and work. Comparative cost‐effectiveness/utility studies, the majority of which are based on modelling techniques, have consistently shown a better cost‐effectiveness ratio of the newer antidepressants over more traditional tricyclic antidepressants (TCAs), when all therapy‐related costs are taken into account.

Url:
DOI: 10.1111/j.1600-0447.1998.tb09995.x


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Economic comparisons of the pharmacotherapy of depression: an overview</title>
<author>
<name sortKey="Crott, R" sort="Crott, R" uniqKey="Crott R" first="R." last="Crott">R. Crott</name>
</author>
<author>
<name sortKey="Gilis, P" sort="Gilis, P" uniqKey="Gilis P" first="P." last="Gilis">P. Gilis</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:012ACD1C71D7DE54000254AC9B500D3543F595B8</idno>
<date when="1998" year="1998">1998</date>
<idno type="doi">10.1111/j.1600-0447.1998.tb09995.x</idno>
<idno type="url">https://api-v5.istex.fr/document/012ACD1C71D7DE54000254AC9B500D3543F595B8/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001F19</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001F19</idno>
<idno type="wicri:Area/Istex/Curation">001F19</idno>
<idno type="wicri:Area/Istex/Checkpoint">001543</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001543</idno>
<idno type="wicri:doubleKey">0001-690X:1998:Crott R:economic:comparisons:of</idno>
<idno type="wicri:Area/Main/Merge">004000</idno>
<idno type="wicri:Area/Main/Curation">003985</idno>
<idno type="wicri:Area/Main/Exploration">003985</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Economic comparisons of the pharmacotherapy of depression: an overview</title>
<author>
<name sortKey="Crott, R" sort="Crott, R" uniqKey="Crott R" first="R." last="Crott">R. Crott</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Faculty of Pharmacy, University of Montreal, Montreal</wicri:regionArea>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
<affiliation wicri:level="3">
<country xml:lang="fr">Canada</country>
<wicri:regionArea>R. Crott, Faculté de Pharmacie, Université de Montreal, succursale Centre‐Ville, Pavilion Principal CP 6128, Montreal</wicri:regionArea>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Gilis, P" sort="Gilis, P" uniqKey="Gilis P" first="P." last="Gilis">P. Gilis</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Eli Lilly Benelux, Brussels</wicri:regionArea>
<placeName>
<settlement type="city">Bruxelles</settlement>
<region nuts="2">Région de Bruxelles-Capitale</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Acta Psychiatrica Scandinavica</title>
<idno type="ISSN">0001-690X</idno>
<idno type="eISSN">1600-0447</idno>
<imprint>
<publisher>Blackwell Publishing Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="1998-04">1998-04</date>
<biblScope unit="volume">97</biblScope>
<biblScope unit="issue">4</biblScope>
<biblScope unit="page" from="241">241</biblScope>
<biblScope unit="page" to="252">252</biblScope>
</imprint>
<idno type="ISSN">0001-690X</idno>
</series>
<idno type="istex">012ACD1C71D7DE54000254AC9B500D3543F595B8</idno>
<idno type="DOI">10.1111/j.1600-0447.1998.tb09995.x</idno>
<idno type="ArticleID">ACPS241</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0001-690X</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>cost‐effectiveness</term>
<term>depression</term>
<term>selective serotonin reuptake inhibitors</term>
<term>tricyclic antidepressants</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">As many countries find that their health care expenditure is taking up an increasing proportion of their financial resources, economic aspects of care processes have become more important in the choice of optimal strategies. This review of the economic studies of the comparative treatment of depression shows that nearly every aspect of treatment has important economic consequences. Cost‐of‐illness studies have documented the high burden on society of this disorder, and the associated loss of productivity and work. Comparative cost‐effectiveness/utility studies, the majority of which are based on modelling techniques, have consistently shown a better cost‐effectiveness ratio of the newer antidepressants over more traditional tricyclic antidepressants (TCAs), when all therapy‐related costs are taken into account.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Belgique</li>
<li>Canada</li>
</country>
<region>
<li>Québec</li>
<li>Région de Bruxelles-Capitale</li>
</region>
<settlement>
<li>Bruxelles</li>
<li>Montréal</li>
</settlement>
</list>
<tree>
<country name="Canada">
<region name="Québec">
<name sortKey="Crott, R" sort="Crott, R" uniqKey="Crott R" first="R." last="Crott">R. Crott</name>
</region>
<name sortKey="Crott, R" sort="Crott, R" uniqKey="Crott R" first="R." last="Crott">R. Crott</name>
</country>
<country name="Belgique">
<region name="Région de Bruxelles-Capitale">
<name sortKey="Gilis, P" sort="Gilis, P" uniqKey="Gilis P" first="P." last="Gilis">P. Gilis</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003985 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003985 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:012ACD1C71D7DE54000254AC9B500D3543F595B8
   |texte=   Economic comparisons of the pharmacotherapy of depression: an overview
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022